Intervention Trial to Decrease Cardiovascular Risk in Persons With Serious Mental Illness
NCT ID: NCT02127671
Last Updated: 2025-08-11
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
269 participants
INTERVENTIONAL
2013-12-12
2018-11-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Depression Treatment and Risk for Cardiovascular Disease
NCT06170255
Life Goals Behavioral Change to Improve Outcomes for Veterans With Serious Mental Illness
NCT01244854
Treatment for Depressed, Obese Individuals at Risk for Cardiovascular Disease (CVD)
NCT01692574
Comorbid Mental Disease and Heart Disease in Men
NCT03354351
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
NCT05962879
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IDEAL intervention
Individual cardiovascular risk reduction counseling, coordination with primary care providers to ensure appropriate management of risk factors, and collaboration with mental health staff and social supports. All participants will be offered group exercise classes, and programs will be provided with instruction to provide more healthy meals.
IDEAL intervention
Control
All participants will be offered group exercise classes, and programs will be provided with instruction to provide more healthy meals.
Control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IDEAL intervention
Control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
▪ Body mass index at least 25 kg/m2 OR one of the following CVD risk factors:
* Hypertension (SBP\>= 140mmHg or DBP\>= 90mmHg or on antihypertensive medications;
* Diabetes mellitus (fasting blood sugar\> 125mg/dl or hemoglobin A1c\>6.5 or on a hypoglycemic medication);
* Dyslipidemia (LDL \>130 mg/dl , HDL\<40 or total cholesterol \>=200 or on a lipid lowering agent);
* Current tobacco smoker
* Able and willing to give informed consent
* Completion of baseline data collection
* Willing to accept randomization
* Willing to participate in the intervention
Exclusion Criteria
* Serious medical condition which either limits life expectancy or requires active management (e.g., certain cancers)
* Condition which interferes with outcome measurement (e.g., dialysis)
* Pregnant or planning a pregnancy during study period. Nursing mothers would need approval from physician.
* Alcohol or substance use disorder if not sober/abstinent for 30 days
* Planning to leave rehabilitation center or clinic within 6 months or move out of geographic area within 18 months
* Investigator judgment (e.g., for concerns about participant or staff safety)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Johns Hopkins University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gail L. Daumit, MD, MHS
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johns Hopkins ProHealth Clinical Research Facility
Woodlawn, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Daumit GL, Dalcin AT, Dickerson FB, Miller ER, Evins AE, Cather C, Jerome GJ, Young DR, Charleston JB, Gennusa JV 3rd, Goldsholl S, Cook C, Heller A, McGinty EE, Crum RM, Appel LJ, Wang NY. Effect of a Comprehensive Cardiovascular Risk Reduction Intervention in Persons With Serious Mental Illness: A Randomized Clinical Trial. JAMA Netw Open. 2020 Jun 1;3(6):e207247. doi: 10.1001/jamanetworkopen.2020.7247.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NA_00072197
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.